AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2020 Issue 4; Section X-New Technology
Transfusion of Chimeric Antigen Receptor (CAR) T Cell Immunotherapy
New table XW2, Anatomical Regions, Transfusion, provides two new codes to describe the intravenous administration of two immunotherapy products as noted below. Body Part Device/Substance/Technology 3 Peripheral Vein 4 Central Vein 4 Brexucabtagene Autoleucel Immunotherapy 7 Lisocabtagene Maraleucel Immunotherapy Unlike other current chimeric antigen receptor (CAR) T-cell therapy products which are classified in table XW0, Anatomical Regions, Introduction, Brexucabtagene Autoleucel Immunotherapy and Lisocabtagene Maraleucel Immunotherapy are classified under the root operation Transfusion based on the root operation definitions and receipt of public comments. CAR T-cell therapy is comprised of blood/blood products; therefore, the root operation Transfusion is more clinically...
To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com